Healthcare Resource Utilization and Costs for Metastatic Breast Cancer Patients Newly Treated with Human Epidermal Growth Factor Receptor 2 (HER2)-Targeted Agents

Healthcare Resource ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Healthcare Resource Utilization ◽

Targeted Agents ◽

Breast Cancer Patients ◽

Abstract PS9-54: Healthcare costs for metastatic breast cancer patients treated with human epidermal growth factor receptor 2 targeted agents

10.1158/1538-7445.sabcs20-ps9-54 ◽

2021 ◽

Author(s):

Reshma Mahtani ◽

Deepa Lalla ◽

Nina Oestreicher ◽

Augustina Ogbonnaya ◽

Vishal Saundankar ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Healthcare Costs ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Targeted Agents ◽

Breast Cancer Patients ◽

Abstract P3-04-03: Identification, clinical characteristics and treatment outcomes of somatic human epidermal growth factor receptor 2 (ERBB2) mutations in metastatic breast cancer patients

10.1158/1538-7445.sabcs17-p3-04-03 ◽

2018 ◽

Author(s):

L Jongen ◽

G Floris ◽

D Lambrechts ◽

A Laenen ◽

P Neven ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Clinical Characteristics ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Abstract P3-01-04: DETECT V – Expression analysis of human epidermal growth factor receptor 2 and estrogen receptor on circulating tumor cells of metastatic breast cancer patients

10.1158/1538-7445.sabcs18-p3-01-04 ◽

2019 ◽

Author(s):

T Fehm ◽

F Meier-Stiegen ◽

S Riethdorf ◽

B Rack ◽

F-A Taran ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Abstract P1-01-15: DETECT V - Detection of the expression of estrogen receptor and human epidermal growth factor receptor 2 on circulating tumor cells from metastatic breast cancer patients

10.1158/1538-7445.sabcs16-p1-01-15 ◽

2017 ◽

Author(s):

T Fehm ◽

F Meier-Stiegen ◽

S Riethdorf ◽

A Schramm ◽

A Polasik ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Abstract P2-03-05: Identification, clinical characteristics and treatment outcomes of somatic human epidermal growth factor receptor 2 (ERBB2) mutations in metastatic breast cancer patients

10.1158/1538-7445.sabcs16-p2-03-05 ◽

2017 ◽

Author(s):

L Jongen ◽

G Floris ◽

D Lambrechts ◽

A Laenen ◽

P Neven ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Clinical Characteristics ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Serum epidermal growth factor receptor and HER2 expression in primary and metastatic breast cancer patients

Breast Cancer Research ◽

10.1186/bcr1788 ◽

2007 ◽

Vol 9 (6) ◽

Cited By ~ 50

Author(s):

Kristjan S Asgeirsson ◽

Amit Agrawal ◽

Claire Allen ◽

Anthony Hitch ◽

Ian O Ellis ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Her2 Expression ◽

Breast Cancer Patients ◽

Limited human epidermal growth factor receptor 2 discordance in metastatic breast cancer patients treated with trastuzumab, a population based study

European Journal of Cancer ◽

10.1016/j.ejca.2014.01.010 ◽

2014 ◽

Vol 50 (5) ◽

pp. 885-891 ◽

Cited By ~ 5

Author(s):

J.M. van Rooijen ◽

L. de Munck ◽

J.C. de Graaf ◽

S. Siesling ◽

E.G. de Vries ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Population Based ◽

Breast Cancer Patients ◽

Population Based Study ◽

DETECT V – expression of human epidermal growth factor receptor 2 and estrogen receptor on circulating tumor cells of metastatic breast cancer patients

10.1055/s-0038-1651759 ◽

2018 ◽

Author(s):

F Meier-Stiegen ◽

S Riethdorf ◽

B Rack ◽

FA Taran ◽

K Pantel ◽

...

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

Phosphorylated S6 Kinase-1 as Predictive Marker of Lapatinib Efficacy in Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer Patients

Journal of Breast Disease ◽

10.14449/jbd.2017.5.2.57 ◽

2017 ◽

Vol 5 (2) ◽

pp. 57-63

Author(s):

Eun-Byeol Ko ◽

Min-Ki Seong ◽

Hyang Suk Choi ◽

Chan Sub Park ◽

Ji Hye Choi ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Predictive Marker ◽

Breast Cancer Patients ◽

S6 Kinase ◽

Lower response to trastuzumab emtansine in metastatic breast cancer patients with human epidermal growth factor receptor 2 immunohistochemistry score of 2 and fluorescence in situ hybridization positive compared with immunohistochemistry score of 3: a retrospective study

Anti-Cancer Drugs ◽

10.1097/cad.0000000000000939 ◽

2020 ◽

Vol 31 (9) ◽

pp. 973-978

Author(s):

Shu Yazaki ◽

Jun Hashimoto ◽

Shin Ogita ◽

Eriko Nakano ◽

Koyu Suzuki ◽

...

Keyword(s):

Breast Cancer ◽

In Situ Hybridization ◽

Growth Factor Receptor ◽

Metastatic Breast ◽

Trastuzumab Emtansine ◽

Breast Cancer Patients ◽